Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | STAT6 | P42226 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | S100A4 | P26447 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9724074 | 0.94 | FBP1 (0.45) | FBP1HPGDMAPTALDH1A1GAA | |
| SCHEMBL17372958 | 0.92 | FBP1 (0.43) | FBP1HPGDMAPTALDH1A1GAA | |
| SCHEMBL27916875 | 0.92 | FBP1 (0.43) | FBP1HPGDMAPTALDH1A1GAA | |
| SCHEMBL20669518 | 0.92 | FBP1 (0.43) | FBP1HPGDMAPTALDH1A1GAA | |
| SCHEMBL5315566 | 0.92 | FBP1 (0.43) | FBP1HPGDMAPTALDH1A1GAA | |
| SCHEMBL28390983 | 0.92 | FBP1 (0.43) | FBP1HPGDMAPTALDH1A1GAA | |
| SCHEMBL10365892 | 0.88 | — | — | |
| Ammonia Solution, Strong SCHEMBL7247507 | 0.86 | FBP1 (0.48) | FBP1HPGDMAPTALDH1A1GAA | |
| SCHEMBL28607626 | 0.80 | FBP1 (0.46) | FBP1HPGDMAPTALDH1A1HTT | |
| SCHEMBL6369341 | 0.80 | FBP1 (0.46) | FBP1HPGDMAPTALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109817979-B | Thiophene-1, 1-dioxane polymer as lithium battery positive electrode active material, and preparation method and application thereof | 华北水利水电大学 | 2021-06-29 | — | — | CN | disclosed |
| US-10000450-B2 | N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2018-06-19 | — | — | US | disclosed |
| US-10000450-B2 | N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2018-06-19 | — | — | US | disclosed |
| CN-108165140-A | Electroactive coating and composition for forming the same | 博九通科技股份有限公司 | 2018-06-15 | — | — | CN | disclosed |
| CN-105295008-B | Electroactive polymer solution or coating, composition and method for forming same, capacitor and method for making same, and antistatic article | 博九通科技股份有限公司 | 2018-02-27 | — | — | CN | disclosed |
| US-20170166524-A1 | N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2017-06-15 | — | — | US | disclosed |
| US-20170166524-A1 | N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2017-06-15 | — | — | US | disclosed |
| EP-3157976-A1 | COMPOSITION AND METHOD FOR FORMING ELECTROACTIVE POLYMER SOLUTION OR COATING COMPRISING CONJUGATED HETEROAROMATIC POLYMER, ELECTROACTIVE POLYMER SOLUTION, CAPACITOR AND ANTISTATIC OBJECT COMPRISING THE ELECTROACTIVE COATING, AND SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR FABRICATING THE SAME | Polym Technology Corporation (CN) | 2017-04-26 | — | — | EP | disclosed |
| US-9611214-B2 | N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2017-04-04 | — | — | US | disclosed |
| US-9611214-B2 | N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2017-04-04 | — | — | US | disclosed |
| EP-1424942-B1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | UNIV MONTANA STATE (US) | 2008-12-31 | — | — | EP | disclosed |
| EP-1424942-A4 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | UNIV MONTANA STATE (US) | 2005-11-23 | — | — | EP | disclosed |
| US-6953570-B2 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | MONTANA STATE UNIVERSITY (US) | 2005-10-11 | — | — | US | disclosed |
| EP-1424942-A1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | Montana State University-Bozeman (US) | 2004-06-09 | — | — | EP | disclosed |
| US-20030105070-A1 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | NICKEL JOINT TRUST, THE | 2003-06-05 | — | — | US | disclosed |
| WO-2003017846-A1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | MONTANA STATE UNIVERSITY-BOZEMAN (US) | 2003-03-06 | — | — | WO | disclosed |
| EP-0664825-B1 | THIO-ESTER COMPOUNDS AND MIXTURES AND DEVICES CONTAINING SUCH COMPOUNDS | SECR DEFENCE BRIT (GB) | 1999-03-31 | — | — | EP | disclosed |
| US-5578242-A | LIQUID CRYSTALS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND OF DEFENCE RESEARCH AGENCY (GB) | 1996-11-26 | — | — | US | disclosed |
| EP-0664825-A1 | THIO-ESTER COMPOUNDS AND MIXTURES AND DEVICES CONTAINING SUCH COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND (GB) | 1995-08-02 | — | — | EP | disclosed |
| WO-1994009085-A1 | THIO-ESTER COMPOUNDS AND MIXTURES AND DEVICES CONTAINING SUCH COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND OF THE DEFENCE RESEARCH AGENCY (GB) | 1994-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105070-A1 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | HMBS, PPOX, PAICS | FBP1 3875/4885HPGD 1382/4885MAPT 1431/4885 |
| US-10000450-B2 | N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors | SLC6A2, TPH1, SLC6A3 | FBP1 2660/4885HPGD 1739/4885MAPT 1263/4885 |
| US-20170166524-A1 | N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS | SLC6A2, TPH1, SLC6A3 | FBP1 2660/4885HPGD 1739/4885MAPT 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.